Fatigue

Oncology·MeSH: Fatigue

13 drugs in development·11 companies·9 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
Dr. Xiao Brand Jianli Soft Capsule	China Health Industries Holdings, Inc. (CHHE)
Dr. Xiao Jianli Soft Capsule	China Health Industries Holdings, Inc. (CHHE)
peptideeye restore serum micro circulation booster	REGENEREX PHARMA, INC. (RGPX)
siberian ginseng series	Fuss Brands Corp. (FBDS)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
xcellara	BIOADAPTIVES, INC. (BDPT)

Phase 2(6)

Drug	Company
Ketamine	UNITED THERAPEUTICS Corp (UTHR)
Methylphenidate	Janux Therapeutics, Inc. (JANX)
Methylphenidate	Royalty Pharma plc (RPRX)
Midazolam	UNITED THERAPEUTICS Corp (UTHR)
ph15	Vistagen Therapeutics, Inc. (VTGN)
WAKIX (pitolisant) - Myotonic Dystrophy (DM1)	Harmony Biosciences Holdings, Inc. (HRMY)

Unknown(1)

Drug	Company
poly i	AIM ImmunoTech Inc. (AIM)

BioSniper tracks 13 drugs in development for Fatigue across 11 companies.

There are 9 clinical trials targeting Fatigue tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.